🇺🇸 MRK — Merck & Co., Inc.

Salud Compra
← Volver

Precio actual

146,73 USD

Máx. histórico

156,45

73 días

Split 1048:1000 del 03/06/2021

Caída desde máximo

-6,21%

Rango 52 semanas

85,24 – 156,92

Variación hoy

-0,14%

Cierre anterior

146,94

Rango de hoy

142,80 – 147,48

Volumen hoy

7.462.267

Peor caída histórica

-68,62%

28/12/2000 → 09/03/2009

Recuperado en 1796 días

Volatilidad anualizada ⓘ

25,43%

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Salud
Industria
Drug Manufacturers - General
Empleados
73.000
PER ⓘ
148,21 (puede no estar actualizado)
Dividend yield
2,31% (puede no estar actualizado)
Precio objetivo analistas
161,53 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 1 día
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,4000 USD · Yield: 2,32%
Fecha de pago Importe por participación
15/09/2026 0,8500 USD
15/06/2026 0,8500 USD
16/03/2026 0,8500 USD
15/12/2025 0,8500 USD
15/09/2025 0,8100 USD
16/06/2025 0,8100 USD
17/03/2025 0,8100 USD
16/12/2024 0,8100 USD
16/09/2024 0,7700 USD
17/06/2024 0,7700 USD
14/03/2024 0,7700 USD
14/12/2023 0,7700 USD
14/09/2023 0,7300 USD
14/06/2023 0,7300 USD
14/03/2023 0,7300 USD
Splits Registrados en el histórico de precios
Fecha Ratio
03/06/2021 1048:1000
17/02/1999 2:1
26/05/1992 3:1
26/05/1988 3:1
27/05/1986 2:1
01/06/1972 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
26/12/1997 48,54 49,38 48,52 49,38 +2,22% 1,78% 1.824.358
24/12/1997 50,16 50,16 48,25 48,31 -3,05% 3,80% 2.905.056
23/12/1997 50,27 50,90 49,77 49,83 -1,42% 2,25% 4.495.291
22/12/1997 49,80 50,57 49,14 50,54 +3,23% 2,87% 5.019.501
19/12/1997 49,80 50,18 48,07 48,96 -2,38% 4,25% 9.082.806
18/12/1997 50,57 51,20 49,80 50,16 -2,04% 2,77% 6.270.603
17/12/1997 51,14 51,47 50,33 51,20 +0,59% 2,22% 6.580.811
16/12/1997 50,42 51,14 50,18 50,90 +1,13% 1,89% 5.079.446
15/12/1997 49,86 51,17 49,65 50,33 +0,72% 3,05% 4.907.784
12/12/1997 50,01 50,07 49,05 49,98 +0,12% 2,03% 4.483.344
11/12/1997 49,62 50,69 49,50 49,92 -0,24% 2,40% 6.820.594
10/12/1997 49,74 50,16 49,20 50,04 -0,18% 1,92% 6.314.200
09/12/1997 49,71 50,63 49,56 50,13 +0,30% 2,16% 7.896.890
08/12/1997 49,80 50,07 49,44 49,98 +0,24% 1,26% 5.700.282
05/12/1997 49,29 49,92 48,54 49,86 -0,12% 2,78% 9.102.928
04/12/1997 49,38 50,10 48,90 49,92 +6,76% 2,42% 20.388.002
03/12/1997 45,29 46,88 45,24 46,76 +3,02% 3,62% 12.406.853
02/12/1997 45,47 45,68 45,24 45,38 -0,20% 0,98% 8.859.792
01/12/1997 45,32 45,50 45,21 45,47 +0,51% 0,66% 7.230.990
28/11/1997 45,21 45,32 45,12 45,24 +0,75% 0,46% 1.564.664
26/11/1997 44,85 45,21 44,70 44,91 +0,20% 1,13% 4.857.061
25/11/1997 44,67 45,06 44,31 44,82 +1,55% 1,67% 7.926.862
24/11/1997 44,79 45,00 43,71 44,13 -2,18% 2,86% 7.191.586
21/11/1997 44,13 45,18 43,62 45,12 +2,16% 3,51% 10.782.872
20/11/1997 44,76 45,41 44,13 44,16 -0,27% 2,86% 8.195.779
19/11/1997 43,24 44,64 43,15 44,28 +2,41% 3,45% 5.433.042
18/11/1997 43,54 44,01 43,12 43,24 -0,82% 2,05% 5.189.067
17/11/1997 43,42 43,98 43,39 43,59 +1,18% 1,37% 7.359.266
14/11/1997 41,95 43,24 41,90 43,09 +2,70% 3,20% 7.746.606
13/11/1997 41,81 42,10 40,70 41,95 +1,15% 3,35% 9.136.883